1
Conclusions: Short office visits are provided to a particularly vulnerable patient population.
2
More studies are needed to investigate its efficacy in this patient population.
3
The benefit of HER2-targeted therapy in this patient population requires further study.
4
Previous studies have indicated that TAVI is feasible in this patient population.
5
It affects a broad patient population and can be difficult to treat.
6
Finally, participation in clinical trials is especially encouraged in this patient population.
7
Descriptive statistics were calculated to assess the demographics of the patient population.
8
Of these patients , 54 have asymptomatic AF and composed our patient population.
9
Recognition of this association will improve the care of this patient population.
10
Results: All four record systems could deliver basic data on the patient population.
11
Results: The mean age of the patient population was 56 years.
12
Therefore, it cannot be used as a screening method in this patient population.
13
Conclusions: No patient population could be identified with minimal risk of non-SLN metastasis.
14
Then it tested a lower risk group, and finally the overall patient population.
15
Such analyses are useful in estimating the health burden in this patient population.
16
The safety and efficacy results warrant further confirmatory studies in this patient population.
